Toxic effects of arsenic (As3+) and other metal ions on acute promyelocytic leukemia cells

International Journal of Hematology

Volumn 65, Issue 2, 1997, Pages 179-185

  Kitamura, Kunio ^a   Yoshida, Hitoshi ^a   Ohno, Ryuzo ^b   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute promyelocytic leukemia; Arsenic; Metal ions

Indexed keywords

ARSENIC; CADMIUM; GALLIUM; GERMANIUM; METAL ION; RETINOIC ACID; SELENIUM; ZINC;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

EID: 0031081669     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(96)00547-6     Document Type: Article

References (11)

1. [1] Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988:72:567-572.
2. [2] Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P. Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990;76:1704-1709.
3. [3] Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994;83:10-25.
4. [4] Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Sato K, Matsuda S, Minato K, Ueda T, Ohno R, the Japan Adult Leukemia Study Group. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 1995;85:1202-1206.
5. [5] Warrell Jr R. Retinoid resistance in acute promyelocytic leukemia: new mechanism, strategies, and implications. Blood 1993;82:1949-1953.
6. [6] Lanotte M, Martin-Thouvenin V, Najiman S, Balerini P, Valensi F, Berger R. NB4. a maturation inducible cell line with t(15:17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991;77:1080-1086.
7. [7] Wada H. Experimental studies on arsenic poisoning. I. Relationship between excretion of arsenic and concentration of arsenic in tissues during acute arsenic poisoning. Shonika-kiyo 1957;3:595-609.
8. [8] Williams G, Smith C. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993;74:777-779.
9. [9] el Azzouzi B, Tsangaris GT, Pellegrini O, Manuel Y, Benveniste J, Thomas Y. Cadmium induces apoptosis in a human T cell line. Toxicology 1994;88:127-139.
10. [10] Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F. Grignani F, Pelicci, PG. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994;83:10-25.
11. [11] Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T. Accelerated degradation of PML-RARA oncoprotein by all-trans retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res 1996;56:2945-2948.